Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

INTRODUCTION: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced ART in resource limited settings, the benefits of continued CTX prophylaxis are not known. The few studies that investigated the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Contemp Clin Trials
Autori principali: Anywaine, Zacchaeus, Abaasa, Andrew, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Grosskurth, Heiner, Munderi, Paula, Nunn, Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542218/
https://ncbi.nlm.nih.gov/pubmed/26009024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.05.015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi